Trial Profile
Two center evaluation of the safety and efficacy of topical nasal rEV131 [recombinant EV 131] versus rEV131 vehicle (placebo) in the prevention of the signs and symptoms of allergic rhinitis induced by nasal allergen challenge,
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs EV 131 (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Sponsors Evolutec
- 22 Dec 2005 New trial record.